Payment overview · 2025
General Payments
2 reported records · 2 companies
Healthcare provider profile · identity verified
Allopathic & Osteopathic Physicians|Internal Medicine · SAN LUIS OBISPO, CA · NPI 1154346377
Verified facts
CMS Open Payments records show Jeffrey M Bloom, MD received $47.49 in general payments during 2025 across 2 reported records.
ANI Pharmaceuticals, Inc. accounted for 62.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
2 reported records · 2 companies
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ANI Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $29.86 | 62.9% | 1 | 2025 |
| Currax Pharmaceuticals LLC | Unresolved — no canonical attribution shown | $17.63 | 37.1% | 1 | 2025 |
What were the payments for?
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $47.49 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| PURIFIED CORTROPHIN GEL Normalized: purified cortrophin gel |
Drug | ANI Pharmaceuticals, Inc. | $29.86 | 1 | 2025 |
Source payment records
|
|||||
| CONTRAVE Normalized: contrave |
Drug | Currax Pharmaceuticals LLC | $17.63 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 286 | 71 |
| Amlodipine Besylate | Amlodipine Besylate | 236 | 69 |
| Atorvastatin Calcium | Atorvastatin Calcium | 233 | 64 |
| Metoprolol Succinate | Metoprolol Succinate | 190 | 54 |
| Valsartan | Valsartan | 170 | 51 |
| Metformin Hcl | Metformin Hcl | 154 | 41 |
| Lisinopril | Lisinopril | 152 | 41 |
| Eliquis | Apixaban | 119 | 25 |
| Omeprazole | Omeprazole | 119 | 35 |
| Losartan Potassium | Losartan Potassium | 109 | 28 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 104 | 50 |
| Hydrochlorothiazide | Hydrochlorothiazide | 98 | 27 |
| Trazodone Hcl | Trazodone Hcl | 93 | 26 |
| Sertraline Hcl | Sertraline Hcl | 91 | 27 |
| Potassium Chloride | Potassium Chloride | 85 | 24 |
| Famotidine | Famotidine | 83 | 29 |
| Gabapentin | Gabapentin | 80 | 24 |
| Pravastatin Sodium | Pravastatin Sodium | 78 | 21 |
| Spironolactone | Spironolactone | 77 | 25 |
| Finasteride | Finasteride | 75 | 21 |
| Zolpidem Tartrate | Zolpidem Tartrate | 70 | 25 |
| Pantoprazole Sodium | Pantoprazole Sodium | 67 | 22 |
| Fluticasone Propionate | Fluticasone Propionate | 61 | 27 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 60 | 17 |
| Furosemide | Furosemide | 58 | 18 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 58 | 13 |
| Tamsulosin Hcl | Tamsulosin Hcl | 58 | 17 |
| Prednisone | Prednisone | 57 | 24 |
| Ozempic | Semaglutide | 55 | suppressed |
| Calcitriol | Calcitriol | 53 | 17 |
| Doxycycline Hyclate | Doxycycline Hyclate | 52 | 42 |
| Estradiol | Estradiol | 51 | 19 |
| Paxlovid | Nirmatrelvir/Ritonavir | 51 | 49 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 50 | 35 |
| Minoxidil | Minoxidil | 47 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 45 | 12 |
| Allopurinol | Allopurinol | 43 | 16 |
| Fluoxetine Hcl | Fluoxetine Hcl | 42 | suppressed |
| Bupropion Xl | Bupropion Hcl | 40 | 11 |
| Carvedilol | Carvedilol | 40 | 13 |
| Tizanidine Hcl | Tizanidine Hcl | 40 | 12 |
| Valacyclovir | Valacyclovir Hcl | 39 | 14 |
| Hydralazine Hcl | Hydralazine Hcl | 38 | 12 |
| Duloxetine Hcl | Duloxetine Hcl | 37 | suppressed |
| Alprazolam | Alprazolam | 36 | suppressed |
| Synthroid | Levothyroxine Sodium | 36 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 35 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 35 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 34 | 25 |
| Glimepiride | Glimepiride | 34 | suppressed |
| Lorazepam | Lorazepam | 34 | 16 |
| Azithromycin | Azithromycin | 33 | 26 |
| Doxepin Hcl | Doxepin Hcl | 33 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 31 | 11 |
| Amoxicillin | Amoxicillin | 30 | 21 |
| Naproxen | Naproxen | 30 | 15 |
| Gemfibrozil | Gemfibrozil | 29 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 29 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 29 | suppressed |
| Pregabalin | Pregabalin | 29 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 28 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 28 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 27 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 27 | suppressed |
| Levetiracetam | Levetiracetam | 26 | suppressed |
| Acyclovir | Acyclovir | 25 | suppressed |
| Simvastatin | Simvastatin | 25 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 23 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 23 | suppressed |
| Pulmicort Flexhaler | Budesonide | 23 | suppressed |
| Trulicity | Dulaglutide | 23 | suppressed |
| Celecoxib | Celecoxib | 22 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 22 | suppressed |
| Dutasteride | Dutasteride | 22 | suppressed |
| Colchicine | Colchicine | 20 | 11 |
| Nifedipine Er | Nifedipine | 20 | suppressed |
| Atenolol | Atenolol | 19 | suppressed |
| Baclofen | Baclofen | 19 | suppressed |
| Metronidazole | Metronidazole | 19 | 17 |
| Telmisartan | Telmisartan | 19 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 18 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 18 | suppressed |
| Metoprolol Tartrate | Metoprolol Tartrate | 18 | suppressed |
| Mirtazapine | Mirtazapine | 18 | suppressed |
| Mounjaro | Tirzepatide | 18 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 17 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 17 | 11 |
| Zafirlukast | Zafirlukast | 17 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 16 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 16 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 16 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 16 | suppressed |
| Tadalafil | Tadalafil | 16 | suppressed |
| Xarelto | Rivaroxaban | 16 | suppressed |
| Irbesartan | Irbesartan | 15 | suppressed |
| Letrozole | Letrozole | 15 | suppressed |
| Mupirocin | Mupirocin | 15 | 14 |
| Myrbetriq | Mirabegron | 15 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 15 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 15 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 14 | suppressed |
| Ezetimibe | Ezetimibe | 14 | suppressed |
| Loperamide | Loperamide Hcl | 14 | suppressed |
| Misoprostol | Misoprostol | 14 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 14 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 14 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 14 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 14 | suppressed |
| Yuvafem | Estradiol | 14 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 13 | suppressed |
| Ondansetron Odt | Ondansetron | 13 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 13 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 12 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 12 | suppressed |
| Phenobarbital | Phenobarbital | 12 | suppressed |
| Polymyxin B Sul-Trimethoprim | Polymyxin B Sulf/Trimethoprim | 12 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 12 | suppressed |
| Risperidone | Risperidone | 12 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 11 | suppressed |
| Cabenuva | Cabotegravir/Rilpivirine | 11 | suppressed |
| Nadolol | Nadolol | 11 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $47.49 · 2 records | ANI Pharmaceuticals, Inc. | CONTRAVE, PURIFIED CORTROPHIN GEL | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error